Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
130M
-
Shares change
-
+6.42M
-
Total reported value, excl. options
-
$2.48B
-
Value change
-
+$67.5M
-
Put/Call ratio
-
2.24
-
Number of buys
-
140
-
Number of sells
-
-121
-
Price
-
$19.12
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2024
304 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q2 2024.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (11.2M shares), VANGUARD GROUP INC (11.1M shares), BlackRock Inc. (8.69M shares), RA CAPITAL MANAGEMENT, L.P. (8.51M shares), FMR LLC (6.13M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (5.03M shares), JPMORGAN CHASE & CO (4.35M shares), Engaged Capital LLC (4.11M shares), Rock Springs Capital Management LP (4.08M shares), and EVENTIDE ASSET MANAGEMENT, LLC (3.74M shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.